Estrella Immunopharma Stock Price Prediction
| ESLA Stock | 1.14 0.10 9.62% |
Oversold Vs Overbought
40
Oversold | Overbought |
Using Estrella Immunopharma hype-based prediction, you can estimate the value of Estrella Immunopharma from the perspective of Estrella Immunopharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Estrella Immunopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Estrella because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Estrella Immunopharma after-hype prediction price | USD 1.17 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Estrella |
Estrella Immunopharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Estrella Immunopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Estrella Immunopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Estrella Immunopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Estrella Immunopharma Estimiated After-Hype Price Volatility
In the context of predicting Estrella Immunopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Estrella Immunopharma's historical news coverage. Estrella Immunopharma's after-hype downside and upside margins for the prediction period are 0.06 and 8.33, respectively. We have considered Estrella Immunopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Estrella Immunopharma is abnormally volatile at this time. Analysis and calculation of next after-hype price of Estrella Immunopharma is based on 3 months time horizon.
Estrella Immunopharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Estrella Immunopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Estrella Immunopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Estrella Immunopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.30 | 7.11 | 0.01 | 0.12 | 2 Events / Month | 7 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.14 | 1.17 | 2.63 |
|
Estrella Immunopharma Hype Timeline
Estrella Immunopharma is currently traded for 1.14. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.12. Estrella is expected to increase in value after the next headline, with the price projected to jump to 1.17 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 2.63%, whereas the daily expected return is currently at 0.3%. The volatility of related hype on Estrella Immunopharma is about 1718.43%, with the expected price after the next announcement by competition of 1.02. Estrella Immunopharma currently holds 180.7 K in liabilities. Given the investment horizon of 90 days the next expected press release will be in a few days. Check out Estrella Immunopharma Basic Forecasting Models to cross-verify your projections.Estrella Immunopharma Related Hype Analysis
Having access to credible news sources related to Estrella Immunopharma's direct competition is more important than ever and may enhance your ability to predict Estrella Immunopharma's future price movements. Getting to know how Estrella Immunopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Estrella Immunopharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ABEV | Ambev SA ADR | 0.02 | 9 per month | 0.00 | (0.18) | 2.20 | (2.69) | 6.42 | |
| SAM | Boston Beer | (4.92) | 11 per month | 1.46 | 0.06 | 2.83 | (2.35) | 6.57 | |
| FIZZ | National Beverage Corp | 0.09 | 8 per month | 1.04 | (0) | 2.21 | (1.89) | 6.35 | |
| BUD | Anheuser Busch Inbev | 0.13 | 9 per month | 0.00 | (0.26) | 1.36 | (2.02) | 9.38 | |
| WEST | Westrock Coffee | 0.14 | 11 per month | 0.00 | (0.05) | 5.66 | (6.23) | 17.90 | |
| CNP | CenterPoint Energy | (0.20) | 12 per month | 0.95 | 0.13 | 1.80 | (1.74) | 5.92 | |
| KDP | Keurig Dr Pepper | (0.21) | 10 per month | 0.00 | (0.23) | 1.46 | (2.08) | 6.67 | |
| ATO | Atmos Energy | 1.64 | 8 per month | 0.31 | 0.14 | 1.85 | (1.17) | 3.85 |
Estrella Immunopharma Additional Predictive Modules
Most predictive techniques to examine Estrella price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Estrella using various technical indicators. When you analyze Estrella charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Estrella Immunopharma Predictive Indicators
The successful prediction of Estrella Immunopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Estrella Immunopharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Estrella Immunopharma based on analysis of Estrella Immunopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Estrella Immunopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Estrella Immunopharma's related companies.
Story Coverage note for Estrella Immunopharma
The number of cover stories for Estrella Immunopharma depends on current market conditions and Estrella Immunopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Estrella Immunopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Estrella Immunopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Estrella Immunopharma Short Properties
Estrella Immunopharma's future price predictability will typically decrease when Estrella Immunopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Estrella Immunopharma often depends not only on the future outlook of the potential Estrella Immunopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Estrella Immunopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.3 M |
Complementary Tools for Estrella Stock analysis
When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance |